About Zach Scheiner
Form D filings for Lenz Therapeutics from 2022 to 2023 list Zach Scheiner as director.
Zach Scheiner first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Zach Scheiner in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Zach Scheiner works with at each company, as listed on that company's latest Form D.
Lenz Therapeutics, Inc. · Form D, Mar 10, 2023
ES
Evert Schimmelpennink
President & CEO, director
JM
James McCollum
Director
CO
Clare Ozawa
Director
SL
Stefan Larson
Director
FG
Frederic Guerard
Director
Chris Dimitropoulos
Director